Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-24-000018
Filing Date
2024-02-08
Accepted
2024-02-08 10:03:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 35710
  Complete submission text file 0000902219-24-000018.txt   37599
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88403 | Film No.: 24607209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)